Table 6 Direct costs (NIS by type) of comorbidities related to overweight and obesity in Israeli adults (2016)
From: Mortality, hospital days and treatment costs of current and reduced sugar consumption in Israel
| Â | Hospital care | Other care | Drugs excl hosp | Total cost | Â |
|---|---|---|---|---|---|
Coronary artery disease | 591,658,411 | 242,594,993 | 221,662,363 | 1,055,915,767 | 22.2% |
Hypertension | 61,099,650 | 395,143,788 | 486,943,218 | 943,186,656 | 19.8% |
Diabetes type II | 206,869,057 | 181,625,245 | 122,819,461 | 511,313,763 | 10.7% |
Stroke | 370,683,266 | 112,966,069 | 6,687,680 | 490,337,015 | 10.3% |
Congestive heart failure | 296,083,592 | 105,115,078 | 61,756,121 | 462,954,791 | 9.7% |
Asthma | 41,796,206 | 109,329,885 | 109,420,510 | 260,546,602 | 5.5% |
Osteoarthritis | 108,937,052 | 75,063,697 | 63,894,529 | 247,895,278 | 5.2% |
Colorectal cancer | 144,207,495 | 64,220,043 | 12,361,287 | 220,788,825 | 4.6% |
Breast cancer | 47,387,005 | 56,090,016 | 21,242,451 | 124,719,472 | 2.6% |
Gallbladder disease | 77,257,439 | 30,853,722 | 7,511,140 | 115,622,301 | 2.4% |
Pulmonary embolism | 52,141,557 | 23,642,864 | 17,849,358 | 93,633,779 | 2.0% |
Pancreatic cancer | 35,098,638 | 14,772,528 | 2,665,719 | 52,536,885 | 1.1% |
Prostate cancer | 22,111,658 | 21,229,074 | 5,919,193 | 49,259,925 | 1.0% |
Kidney cancer | 26,858,616 | 15,474,832 | 3,735,304 | 46,068,752 | 1.0% |
Ovarian cancer | 19,039,091 | 8,197,386 | 1,514,473 | 28,750,951 | 0.6% |
Endometrial cancer | 14,533,230 | 10,957,594 | 3,085,428 | 28,576,252 | 0.6% |
Oesophageal cancer | 16,018,731 | 6,573,203 | 1,132,359 | 23,724,293 | 0.5% |
Non-alcoholic fatty liver | 2,054,218 | 1,341,950 | 1,017,803 | 4,413,971 | 0.1% |
Gout | 1,586,644 | 1,036,499 | 786,134 | 3,409,277 | 0.1% |
Total | 2,135,421,555 | 1,476,228,468 | 1,152,004,532 | 4,763,654,555 | 100.0% |